BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7552213)

  • 21. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia.
    Shimizu Y; Tada Y; Yamauchi M; Okamoto T; Suzuki H; Ito N; Fukumoto S; Sugimoto T; Fujita T
    Bone; 2009 Oct; 45(4):814-6. PubMed ID: 19555782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical aspect of recent progress in phosphate metabolism. Hyperphosphatemia and hypophosphatemia].
    Michigami T
    Clin Calcium; 2009 Jun; 19(6):785-92. PubMed ID: 19483272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sinonasal hemangiopericytomas: a clinicopathologic and immunohistochemical study of seven cases.
    Catalano PJ; Brandwein M; Shah DK; Urken ML; Lawson W; Biller HF
    Head Neck; 1996; 18(1):42-53. PubMed ID: 8774921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal and neonatal hepatic tumors.
    Isaacs H
    J Pediatr Surg; 2007 Nov; 42(11):1797-803. PubMed ID: 18022426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated serum FGF23 concentrations in plasma cell dyscrasias.
    Stewart I; Roddie C; Gill A; Clarkson A; Mirams M; Coyle L; Ward C; Clifton-Bligh P; Robinson BG; Mason RS; Clifton-Bligh RJ
    Bone; 2006 Aug; 39(2):369-76. PubMed ID: 16644301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-induced osteomalacia: successful treatment by radio-guided tumor surgery.
    Harbeck B; Schöcklmann H; Seekamp A; Czech N; Mönig H
    J Clin Rheumatol; 2009 Feb; 15(1):31-4. PubMed ID: 19125132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphaturic mesenchymal tumor diagnosed by fine-needle aspiration and core biopsy: a case report and review of literature.
    Policarpio-Nicolas ML; Abbott TE; Dalkin AC; Bennett-Wick J; Frierson HF
    Diagn Cytopathol; 2008 Feb; 36(2):115-9. PubMed ID: 18181193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Osteomalacia and giant cell tumor: a rare case].
    Sehli H; Daoud L; Ben Mbarek R; Ghorbel R; Ben Abdelghani K; Charfi H; Cheour I; Tarhouni L; Sellami S
    Tunis Med; 2008 Sep; 86(9):836-8. PubMed ID: 19472787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone densitometry in a patient with hypophosphatemic osteomalacia.
    Negri AL; Bogado CE; Zanchetta JR
    J Bone Miner Metab; 2004; 22(5):514-7. PubMed ID: 15316875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypophosphatemic osteomalacia: a report of five cases and evaluation of bone markers.
    Ros I; Alvarez L; Guañabens N; Peris P; Monegal A; Vázquez I; Cerdá D; Ballesta AM; Muñoz-Gómez J
    J Bone Miner Metab; 2005; 23(3):266-9. PubMed ID: 15838631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypophosphatemic osteomalacia secondary to a vascular fibrous histiocytoma].
    Insua Vilariño SA; Díaz Garel J; Caamaño Freire M; Mera Varela A; Buelta Carrillo L; Pérez Becerra E; Varela Durán J
    Rev Clin Esp; 1993 Oct; 193(6):293-5. PubMed ID: 8259452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tumoral hypophosphatemic osteomalacia].
    Santamaría Sandi J; Elorza Olabegoya R; Beitia Martín JJ; Vázquez García JA
    Med Clin (Barc); 1985 Jun; 85(5):191-3. PubMed ID: 2991677
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of tumor-induced osteomalacia on the bone mineralization process.
    Nawrot-Wawrzyniak K; Varga F; Nader A; Roschger P; Sieghart S; Zwettler E; Roetzer KM; Lang S; Weinkamer R; Klaushofer K; Fratzl-Zelman N
    Calcif Tissue Int; 2009 Apr; 84(4):313-23. PubMed ID: 19219382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia.
    Rowe PS; Ong AC; Cockerill FJ; Goulding JN; Hewison M
    Bone; 1996 Feb; 18(2):159-69. PubMed ID: 8833210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-induced osteomalacia and rickets.
    Nuovo MA; Dorfman HD; Sun CC; Chalew SA
    Am J Surg Pathol; 1989 Jul; 13(7):588-99. PubMed ID: 2544116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vitamin D-resistant rickets].
    Grzanka K; Kucharz EJ
    Wiad Lek; 2004; 57(11-12):663-71. PubMed ID: 15865246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteomalacia with hypophosphatemia and hypercalciuria: a possible new variant of osteomalacia.
    Slyper AH; Shaker JL; Thometz JG; McCormick K
    J Pediatr; 1995 Jul; 127(1):105-9. PubMed ID: 7608793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis.
    Konishi K; Nakamura M; Yamakawa H; Suzuki H; Saruta T; Hanaoka H; Davatchi F
    Am J Med Sci; 1991 May; 301(5):322-8. PubMed ID: 1902351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progressive course of hypophosphatemic osteomalacia during 25-year follow up].
    Bojović J; Pavlica L
    Med Pregl; 2010; 63(5-6):419-22. PubMed ID: 21186558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy.
    Sato K; Shiraki M
    Endocr J; 1998 Aug; 45(4):431-9. PubMed ID: 9881891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.